These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 20595649)
1. Lead contributes to arterial intimal hyperplasia through nuclear factor erythroid 2-related factor-mediated endothelial interleukin 8 synthesis and subsequent invasion of smooth muscle cells. Zeller I; Knoflach M; Seubert A; Kreutmayer SB; Stelzmüller ME; Wallnoefer E; Blunder S; Frotschnig S; Messner B; Willeit J; Debbage P; Wick G; Kiechl S; Laufer G; Bernhard D Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1733-40. PubMed ID: 20595649 [TBL] [Abstract][Full Text] [Related]
2. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan. Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809 [TBL] [Abstract][Full Text] [Related]
3. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694 [TBL] [Abstract][Full Text] [Related]
4. BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries. Wang B; Zhang M; Takayama T; Shi X; Roenneburg DA; Kent KC; Guo LW EBioMedicine; 2015 Nov; 2(11):1650-61. PubMed ID: 26870791 [TBL] [Abstract][Full Text] [Related]
5. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia. Ashino T; Yamamoto M; Yoshida T; Numazawa S Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426 [TBL] [Abstract][Full Text] [Related]
6. Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats. Sun Q; Kawamura T; Masutani K; Peng X; Sun Q; Stolz DB; Pribis JP; Billiar TR; Sun X; Bermudez CA; Toyoda Y; Nakao A Cardiovasc Res; 2012 Apr; 94(1):144-53. PubMed ID: 22287575 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis. Lyon CA; Koutsouki E; Aguilera CM; Blaschuk OW; George SJ J Vasc Surg; 2010 Nov; 52(5):1301-9. PubMed ID: 20630685 [TBL] [Abstract][Full Text] [Related]
8. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein. Mughal RS; Scragg JL; Lister P; Warburton P; Riches K; O'Regan DJ; Ball SG; Turner NA; Porter KE Diabetologia; 2010 Aug; 53(8):1761-71. PubMed ID: 20461358 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. Muto A; Panitch A; Kim N; Park K; Komalavilas P; Brophy CM; Dardik A Vascul Pharmacol; 2012; 56(1-2):47-55. PubMed ID: 22024359 [TBL] [Abstract][Full Text] [Related]
10. Endothelial Myocyte Enhancer Factor 2c Inhibits Migration of Smooth Muscle Cells Through Fenestrations in the Internal Elastic Lamina. Lu YW; Lowery AM; Sun LY; Singer HA; Dai G; Adam AP; Vincent PA; Schwarz JJ Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1380-1390. PubMed ID: 28473437 [TBL] [Abstract][Full Text] [Related]
11. Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers. Cheong A; Li J; Sukumar P; Kumar B; Zeng F; Riches K; Munsch C; Wood IC; Porter KE; Beech DJ Cardiovasc Res; 2011 Feb; 89(2):282-9. PubMed ID: 20884640 [TBL] [Abstract][Full Text] [Related]
12. Soluble N-cadherin: A novel inhibitor of VSMC proliferation and intimal thickening. Lyon CA; Wadey KS; George SJ Vascul Pharmacol; 2016 Mar; 78():53-62. PubMed ID: 26586312 [TBL] [Abstract][Full Text] [Related]
13. Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary artery. Huang B; Dreyer T; Heidt M; Yu JC; Philipp M; Hehrlein FW; Katz N; Al-Fakhri N Eur J Cardiothorac Surg; 2002 Jun; 21(6):1002-8. PubMed ID: 12048077 [TBL] [Abstract][Full Text] [Related]
14. Blocking potassium channels: a new principle for treating restenosis? Olschewski A Cardiovasc Res; 2011 Feb; 89(2):255-7. PubMed ID: 21156820 [No Abstract] [Full Text] [Related]
15. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway. Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859 [TBL] [Abstract][Full Text] [Related]
16. Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia. Osgood MJ; Sexton K; Voskresensky I; Hocking K; Song J; Komalavilas P; Brophy C; Cheung-Flynn J J Vasc Surg; 2016 Aug; 64(2):471-478. PubMed ID: 27763268 [TBL] [Abstract][Full Text] [Related]